Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06041282

Conservative Treatment of Early Adhesive Capsulitis

A prospective, multicentre, randomized controlled study comparing the efficacy of conservative treatment for early adhesive capsulitis

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Adhesive Capsulitis Bursitis Joint Diseases Musculoskeletal Diseases

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310058, China

Location status: Recruiting

Location contact

weiliang shen, Doctor

CONTACT

[email protected]

86-0571-86995513

About this study

This clinical trial evaluated the most common protocols for the treatment of adhesive capsulitis in secondary hospitals. To compare the efficacy of manipulation under anesthesia and supervised home conservative treatment of early adhesive capsulitis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients in our hospital who need manual release of periarthritis of shoulder or home rehabilitation treatment;
  • Unilateral and primary periarthritis of shoulder
  • Age ≥40 years old and ≤80 years old, regardless of gender.
  • Forward flexion movement is more than 50% limited compared with the contralateral.
  • Duration of disease ≤3 months

Exclusion criteria

  • Patients with a previous history of shoulder joint surgery
  • Patients who did not complete the follow-up within the specified time
  • Patients with other shoulder diseases.
  • Patient with systemic immune disease.
  • Patients who have participated in clinical trials or are conducting other clinical trials within 3 months before screening
  • Patients with serious primary cardiovascular diseases, lung diseases, endocrine and metabolic diseases, or serious diseases affecting their survival, such as tumor or AIDS, are considered not suitable for admission.
  • Patients with serious liver diseases, kidney diseases, hematological diseases, such as kidney function (BUN, Cr) more than the upper limit of normal, liver function (ALT, AST, TBIL) more than 2 times the upper limit of normal.
  • Patients with viral hepatitis, infectious diseases, abnormal blood coagulation mechanism and other diseases that researchers consider inappropriate for surgery.
  • Pregnant or lactating women, or those planning to get pregnant during the test, with positive urine HCG test results before the test; Menstruating women should wait until their period is over before undergoing surgery.
  • Patients with severe neurological and mental diseases.
  • Suspected or true history of alcohol and drug abuse.

Treatment and study plan

manipulation under anesthesia

Procedure

After the anesthesia took effect, the patient was placed in the supine position, and the experienced surgeon stood at the head of the bed to release the affected limb by four angles of forward flexion, abduction, external rotation and internal rotation. After the operation is completed, 1ml de Bosson (MSD) +2.5ml sodium hyaluronate (Biochemical Industries Co., LTD.) is injected once.

supervised home rehabilitation

Procedure

The doctor instructs the patient in exercise training at the outpatient clinic. At each clinic visit, the doctor will guide the different stages of the movement. At the first visit, the doctor guides the patient through the first phase of the rehabilitation program to improve the patient's basic mobility. At the first month of follow-up, the second phase of rehabilitation program was guided, and the recovery of mobility was accompanied by muscle training, including wall climbing and muscle resistance exercises. 1ml Debossone (MSD) +2.5ml sodium hyaluronate (Biochemical Industries Co., LTD.) was injected once at the clinic. All the training required patients to do their best at home to complete 3 sets of 5 each. At the end of each day, the patient will upload a video to the platform, and the doctor will evaluate whether the patient's recovery is in place.

Primary outcomes

  1. Constant-Murley Score (CMS)

    Time frame: 6months after intervention

    The Constant-Mulery score mainly includes 8 aspects related to your shoulder in the past 4 weeks.

    The proportion of subjective and objective components in the Constant-Mulery score is 35 points/65 points. A total of 100 points.The subjective part of the score includes the score of pain degree and the score of impact on daily life. 35 points in total.The objective part of the score includes the score of shoulder range of motion and strength. 65 points in total.

Secondary outcomes

  1. Constant-Murley Score (CMS)

    Time frame: 1 months, 3months, and 1year after intervention

    The Constant-Mulery score mainly includes 8 aspects related to your shoulder in the past 4 weeks.

    The proportion of subjective and objective components in the Constant-Mulery score is 35 points/65 points. A total of 100 points.The subjective part of the score includes the score of pain degree and the score of impact on daily life. 35 points in total.The objective part of the score includes the score of shoulder range of motion and strength. 65 points in total.

  2. Oxford Shoulder Score (OSS)

    Time frame: 1 months, 3months, 6 months and 1year after intervention

    The Oxford Shoulder Score (OSS) consists of 12 questions with five options each. The light to heavy lines were assigned 1, 2, 3, 4 and 5 points respectively. So the total score is between 12 and 60. A score of 12 represents perfectly normal shoulder function and a score of 60 represents the most severe difficulty in shoulder function.

  3. Fear-avoidance belief questionnaire(FABQ)

    Time frame: 1 months, 3months, 6 months and 1year after intervention

    The FABQ is a self-assessment scale with 16 options. Each option has 0~6 points and 7 grades (from extremely disagreeable to extremely agreed). "0" means completely disagreed, "6" means completely agreed, and "1~5" means not sure. The higher the score, the more inclined to fully agree

  4. Insomnia Severity Index(ISI)

    Time frame: 1 months, 3months, 6 months and 1year after intervention

    The scale is a simple tool for screening insomnia, including 7 items, which are used to evaluate the nature and symptoms of sleep disorders of subjects.

  5. Hospital Anxiety and Depression Scale(HADS)

    Time frame: 1 months, 3months, 6 months and 1year after intervention

    HADS is a self-assessment scale, including two subscales, HADS-A and HADS-D, with a total of 14 items, including 7 items for anxiety (A) and 7 items for depression (D). Each item is scored at four levels according to the frequency of symptoms in the past month. Each item is scored at 0-3 points in four levels. The higher the score, the more serious the anxiety or depression

  6. SF-36

    Time frame: 1 months, 3months, 6 months and 1year after intervention

    SF-36 is a concise health questionnaire developed by the Boston Institute of Health, which is widely used in the measurement of the quality of life of the general population, the evaluation of clinical trials and the evaluation of health policies. SF-36 is used to assess physiological function, physiological function, physical pain, general health, energy, social function, emotional function and mental health, which are classified into "physical health" and "mental health"

  7. Visual analogue scale(VAS)

    Time frame: 1 months, 3months, 6 months and 1year after intervention

    Draw a 10cm horizontal line on the paper. One end of the line is "0", indicating no pain; the other end is "10", indicating severe pain; The middle represents different degrees of pain; Let the patient draw a mark on the horizontal line according to their feelings to indicate the degree of pain.

  8. range of motion

    Time frame: 1 months, 3months, 6 months and 1year after intervention

    Measure the patient's flexion, abduction, internal rotation and external rotation angle

Study contacts

Contact information is provided by the study sponsor or research team.

weiliang shen, doctor

CONTACT

[email protected]

+86 0571 87783759

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Registry information

Official study title

A Multicentre Randomized Controlled Trial of Manipulation Under Anesthesia and Supervised Home Rehabilitation in the Treatment of Early Adhesive Capsulitis

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 18, 2023
Registry last updated
Jan 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.